1. Home
  2. CURV vs BDSX Comparison

CURV vs BDSX Comparison

Compare CURV & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Torrid Holdings Inc.

CURV

Torrid Holdings Inc.

N/A

Current Price

$2.23

Market Cap

253.3M

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$10.26

Market Cap

276.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CURV
BDSX
Founded
2001
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.3M
276.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CURV
BDSX
Price
$2.23
$10.26
Analyst Decision
Hold
Strong Buy
Analyst Count
7
7
Target Price
$2.17
★ $33.83
AVG Volume (30 Days)
164.8K
★ 200.0K
Earning Date
12-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.06
N/A
Revenue
★ $1,000,092,000.00
$88,499,000.00
Revenue This Year
N/A
$26.35
Revenue Next Year
$1.63
$20.40
P/E Ratio
$36.17
★ N/A
Revenue Growth
N/A
★ 24.08
52 Week Low
$0.94
$5.26
52 Week High
$2.86
$31.97

Technical Indicators

Market Signals
Indicator
CURV
BDSX
Relative Strength Index (RSI) 47.69 24.96
Support Level $2.03 N/A
Resistance Level $2.55 $11.57
Average True Range (ATR) 0.20 2.25
MACD -0.01 -1.34
Stochastic Oscillator 31.33 15.26

Price Performance

Historical Comparison
CURV
BDSX

About CURV Torrid Holdings Inc.

Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: